MedPath

Zhejiang Xianju Pharmaceutical Co.,Ltd.

Zhejiang Xianju Pharmaceutical Co.,Ltd. logo
🇨🇳China
Ownership
Public, Subsidiary
Established
2000-06-26
Employees
1.3K
Market Cap
-
Website
http://www.xjpharma.com
Introduction

The company, formerly known as Xianju Pharmaceutical Factory, was founded in 1972. The company carries out the corporate mission of “your health and happiness, my sincerity and responsibility”, and focuses on the field of steroids with the development vision of “becoming the top ten steroidal drug suppliers in the world and becoming an enterprise popular with customers and employees”. The main business is the development, manufacture and sale of steroidal raw materials and formulations. The main products are divided into four categories: corticosteroid drugs, sex hormone drugs (gynecology and family planning drugs), anesthetic muscle relaxants, and respiratory drugs. Company honors include “2003 Excellent Self-operated Export Manufacturer”, “Taizhou Advanced Manufacturing Leading Enterprise”, “Quality Service Integrity Demonstration Unit”, China's Top 100 Pharmaceutical Industry Enterprises, and Zhejiang Water-Saving Benchmark Enterprise. For the first time, the company also received many honors such as “China's Best Industrial Enterprise in Pharmaceutical R&D Product Line”, “National Enterprise Technology Center”, “National Intellectual Property Advantage Enterprise”, and “Zhejiang Intellectual Property Demonstration Enterprise”, and successfully passed the EcoVadis rating to win a silver medal.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

145

NMPA:145

Drug Approvals

Progesterone Soft Capsules

Product Name
黄体酮软胶囊
Approval Number
国药准字H20254090
Approval Date
May 13, 2025
NMPA

Progesterone Soft Capsules

Product Name
黄体酮软胶囊
Approval Number
国药准字H20254091
Approval Date
May 13, 2025
NMPA

Dydrogesterone Tablets

Product Name
地屈孕酮片
Approval Number
国药准字H20254052
Approval Date
Apr 30, 2025
NMPA

Desogestrel and Ethinylestradiol Tablets

Product Name
去氧孕烯炔雌醇片
Approval Number
国药准字H20253564
Approval Date
Mar 4, 2025
NMPA

Beraprost Sodium Tablets

Product Name
贝前列素钠片
Approval Number
国药准字H20253372
Approval Date
Feb 11, 2025
NMPA

Neostigmine Methylsulfate Injection

Product Name
甲硫酸新斯的明注射液
Approval Number
国药准字H20247239
Approval Date
Oct 11, 2024
NMPA

Methylprednisolone Tablets

Product Name
甲泼尼龙片
Approval Number
国药准字H20247189
Approval Date
Aug 15, 2024
NMPA

FINASTERIDE TABLETS

Product Name
先立晓
Approval Number
国药准字H20031186
Approval Date
Aug 9, 2024
NMPA

Pidotimod Granules

Product Name
谱乐益
Approval Number
国药准字H20100104
Approval Date
Aug 7, 2024
NMPA

VECURONIUM BROMIDE FOR INJECTION

Product Name
仙林
Approval Number
国药准字H19991172
Approval Date
Aug 7, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.